×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Galecto Inc. (GLTO) NASDAQ

$0.78 - (-)

Market Cap: $21.15M

As of 03/28/24 04:00 PM EDT. Market closed.

(GLTO)

Galecto Inc. (GLTO)
NASDAQ

$0.78
- (-)

Market Cap: $21.15M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

galecto biotech is a newly founded company, focused on developing novel drugs for the treatment of fibrosis, inflammation and other serious human diseases. the company’s products target galectins, a group of proteins that play important roles in many disorders. galecto biotech’s high potency galectin modulators may open new treatment possibilities for many patients. the company, which is ... read more

galecto biotech is a newly founded company, focused on developing novel drugs for the treatment of fibrosis, inflammation and other serious human diseases. the company’s products target galectins, a group of proteins that play important roles in many disorders. galecto biotech’s high potency galectin modulators may open new treatment possibilities for many patients. the company, which is located in lund, sweden, is led by top-level scientists and biotech executives. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
61
Address
.
PRICE CHART FOR GALECTO INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.81
Previous Close
$0.78
Days Range
$0.74 - $0.84
52 week range
$0.50 - $3.70
Volume
129,262
Avg. Volume (30 days)
339,290
Market Cap
$21.15M
Dividend Yield
-
P/E
-
Shares Outstanding
27,112,697
Open
$0.81
Previous Close
$0.78
Days Range
$0.74 - $0.84
52 week range
$0.50 - $3.70
Volume
129,262
Avg. Volume (30 days)
339,290
Market Cap
$21.15M
Dividend Yield
-
P/E
-
Shares Outstanding
27,112,697
FINANCIAL STATEMENTS FOR GALECTO INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR GALECTO INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
ORBIMED ADVISORS LLC10% OwnerAug 15, 2023 Sale$0.75822,680617,0101,510,375Aug 17, 2023, 04:40 PM
ORBIMED ADVISORS LLC10% OwnerJul 31, 2023 Sale$3.00209,400628,2002,105,909Aug 02, 2023, 05:05 PM
ORBIMED ADVISORS LLC10% OwnerJul 25, 2023 Sale$2.9239,200114,4642,258,987Jul 27, 2023, 04:28 PM
ORBIMED ADVISORS LLC10% OwnerJul 13, 2023 Sale$2.40194,700467,2802,285,687Jul 17, 2023, 04:13 PM
ORBIMED ADVISORS LLC10% OwnerApr 17, 2023 Sale$1.9713,08925,7852,417,787Apr 17, 2023, 05:28 PM
ORBIMED ADVISORS LLC10% OwnerApr 14, 2023 Sale$1.8641,44677,0902,426,665Apr 17, 2023, 05:28 PM
ORBIMED ADVISORS LLC10% OwnerApr 13, 2023 Sale$1.8213,94625,3822,454,775Apr 17, 2023, 05:28 PM
ORBIMED ADVISORS LLC10% OwnerApr 12, 2023 Sale$1.812,3634,2772,464,234Apr 12, 2023, 06:44 PM
ORBIMED ADVISORS LLC10% OwnerApr 11, 2023 Sale$1.8213,94625,3822,465,837Apr 12, 2023, 06:44 PM
ORBIMED ADVISORS LLC10% OwnerApr 10, 2023 Sale$1.7951,22891,6982,500,582Apr 12, 2023, 06:44 PM
ORBIMED ADVISORS LLC10% OwnerApr 06, 2023 Sale$2.009,66519,3302,510,041Apr 07, 2023, 04:42 PM
ORBIMED ADVISORS LLC10% OwnerApr 05, 2023 Sale$2.1892,965202,6642,516,599Apr 07, 2023, 04:42 PM
Lindmark BertilChief Medical OfficerMar 22, 2022 Buy$2.1614,60431,54516,604Mar 23, 2022, 08:00 AM
Schambye Hans T.Chief Executive OfficerMar 22, 2022 Buy$2.155,00010,75052,428Mar 23, 2022, 08:00 AM
Winslow GarrettGeneral CounselDec 03, 2021 Buy$2.482,0004,9604,000Dec 06, 2021, 08:00 AM
Freve JonathanChief Financial OfficerDec 03, 2021 Buy$2.494,0009,96012,000Dec 06, 2021, 08:00 AM
Schambye Hans T.Chief Executive OfficerNov 09, 2021 Buy$3.504,50015,75047,428Nov 10, 2021, 08:00 AM
Freve JonathanChief Financial OfficerNov 08, 2021 Buy$3.403,00010,2008,000Nov 09, 2021, 08:00 AM
Freve JonathanChief Financial OfficerAug 18, 2021 Buy$3.923,00011,7605,000Aug 19, 2021, 04:00 PM
Lindmark BertilChief Medical OfficerJun 28, 2021 Buy$5.262,00010,5202,000Jun 28, 2021, 04:00 PM
Schambye Hans T.Chief Executive OfficerJun 24, 2021 Buy$5.113,00015,33042,928Jun 24, 2021, 04:00 PM
Freve JonathanChief Financial OfficerJun 23, 2021 Buy$4.742,0009,4802,000Jun 23, 2021, 04:00 PM
Winslow GarrettGeneral CounselJun 23, 2021 Buy$4.802,0009,6002,000Jun 23, 2021, 04:00 PM
ORBIMED ADVISORS LLCDirectorNov 02, 2020 Buy$15.00733,33310,999,9952,579,657Nov 04, 2020, 08:00 PM
Khuong Chau QuangDirectorNov 02, 2020 Buy$15.00733,33310,999,9952,579,657Nov 04, 2020, 08:00 PM
Christgau StephanDirectorNov 02, 2020 Buy$15.0066,666999,990546,136Nov 04, 2020, 08:00 PM
Novo Holdings A/S10% OwnerNov 02, 2020 Buy$15.00333,3334,999,9952,497,791Nov 04, 2020, 07:52 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
ORBIMED ADVISORS LLC10% Owner08/15/2023617,010
ORBIMED ADVISORS LLC10% Owner07/31/2023628,200
ORBIMED ADVISORS LLC10% Owner07/25/2023114,464
ORBIMED ADVISORS LLC10% Owner07/13/2023467,280
ORBIMED ADVISORS LLC10% Owner04/17/202325,785
ORBIMED ADVISORS LLC10% Owner04/14/202377,090
ORBIMED ADVISORS LLC10% Owner04/13/202325,382
ORBIMED ADVISORS LLC10% Owner04/12/20234,277
ORBIMED ADVISORS LLC10% Owner04/11/202325,382
ORBIMED ADVISORS LLC10% Owner04/10/202391,698
ORBIMED ADVISORS LLC10% Owner04/06/202319,330
ORBIMED ADVISORS LLC10% Owner04/05/2023202,664
Lindmark BertilChief Medical Officer03/22/202231,545
Schambye Hans T.Chief Executive Officer03/22/202210,750
Winslow GarrettGeneral Counsel12/03/20214,960
Freve JonathanChief Financial Officer12/03/20219,960
Schambye Hans T.Chief Executive Officer11/09/202115,750
Freve JonathanChief Financial Officer11/08/202110,200
Freve JonathanChief Financial Officer08/18/202111,760
Lindmark BertilChief Medical Officer06/28/202110,520
Schambye Hans T.Chief Executive Officer06/24/202115,330
Freve JonathanChief Financial Officer06/23/20219,480
Winslow GarrettGeneral Counsel06/23/20219,600
ORBIMED ADVISORS LLCDirector11/02/202010,999,995
Khuong Chau QuangDirector11/02/202010,999,995
Christgau StephanDirector11/02/2020999,990
Novo Holdings A/S10% Owner11/02/20204,999,995
Load More Insider Transactions
FUNDS WITH A POSITION IN GALECTO INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ORBIMED ADVISORS LLC924,7880.01%ExitedOther
RENAISSANCE TECHNOLOGIES LLC406,9680.00045%98.42%Other
GEODE CAPITAL MANAGEMENT, LLC208,3330.00002%No changeOther
BLACKROCK INC.52,1060%-0.9%Other
CHANGE IN SHARES OUTSTANDING FOR GALECTO INC
STOCK BUYBACKS FOR GALECTO INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.02%
1Q
12/31/2023
06/30/2023
2.79%
2Q
12/31/2023
03/31/2023
5.60%
3Q
12/31/2023
12/31/2022
5.86%
4Q
12/31/2023
09/30/2022
6.35%
5Q
12/31/2023
06/30/2022
7.28%
6Q
12/31/2023
03/31/2022
7.32%
7Q
12/31/2023
12/31/2021
7.32%
8Q
12/31/2023
09/30/2021
7.32%
9Q
12/31/2023
06/30/2021
7.32%
10Q
12/31/2023
03/31/2021
7.32%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.02%
1Q
06/30/2023
2.79%
2Q
03/31/2023
5.60%
3Q
12/31/2022
5.86%
4Q
09/30/2022
6.35%
5Q
06/30/2022
7.28%
6Q
03/31/2022
7.32%
7Q
12/31/2021
7.32%
8Q
09/30/2021
7.32%
9Q
06/30/2021
7.32%
10Q
03/31/2021
7.32%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR GALECTO INC
LOADING...